Company profile for Anterogen Co

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Established a research institute in Boston in 2000, Anterogen began commercializing products using adipose-derived stem cells for the first time in Korea. In January 2012, we obtained a market authorization of Cupistem® injection as an adipose-derived stem cell therapy product for the first time in the world. Anterogen, an emerging global leader in the field of cell therapy products, has developed Adipocell® (for the treatm...
Established a research institute in Boston in 2000, Anterogen began commercializing products using adipose-derived stem cells for the first time in Korea. In January 2012, we obtained a market authorization of Cupistem® injection as an adipose-derived stem cell therapy product for the first time in the world. Anterogen, an emerging global leader in the field of cell therapy products, has developed Adipocell® (for the treatment of depressed scar), Queencell® (for the regeneration of subcutaneous adipose tissue) and Cupistem® injection (for the treatment of Crohn's fistula) etc.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
(Namsung Plaza, Gasan-dong) 405, 130, Digital-ro, Geumcheon-gu, Seoul, 08589
Telephone
Telephone
+82-2-2104-0391~2
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
What will be 1st approved stem cell treatment this year?
What will be 1st approved stem cell treatment this year?

01 Aug 2019

// So Jae-hyeon KOREABIOMED

http://www.koreabiomed.com/news/articleView.html?idxno=2831

So Jae-hyeon KOREABIOMED
01 Aug 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty